| Direct Competitor Comparison | |
|---|
| ARNA | GSK | OREX | RHHBY | Industry |
|---|
| Market Cap: | 1.74B | 126.48B | 559.55M | 214.26B | 71.76B |
|---|
| Employees: | 293 | 99,488 | 41 | 82,089 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.08 | -0.03 | 0.00 | 0.12 | 0.27 |
|---|
| Revenue (ttm):
| 27.77M | 42.21B | 3.43M | 50.83B | 13.93B |
|---|
| Gross Margin (ttm): | 0.54 | 0.71 | 1.00 | 0.75 | 0.72 |
|---|
| EBITDA (ttm): | -48.91M | 14.49B | -98.87M | 20.10B | 1.51B |
|---|
| Operating Margin (ttm):
| -2.11 | 0.28 | -28.93 | 0.34 | 0.13 |
|---|
| Net Income (ttm): | -77.78M | 6.78B | -99.05M | 10.22B | N/A |
|---|
| EPS (ttm): | -0.37 | 2.74 | -1.29 | 2.99 | 0.61 |
|---|
| P/E (ttm): | N/A | 19.09 | N/A | 21.13 | 18.43 |
|---|
| PEG (5 yr expected): | -2.29 | 4.17 | -0.51 | 2.31 | 1.51 |
|---|
| P/S (ttm): | 62.71 | 2.99 | 163.50 | 4.26 | 3.64 |
|---|
|
| GSK = GlaxoSmithKline plc | | OREX = Orexigen Therapeutics, Inc. | | RHHBY = Roche Holding AG | | Industry = Biotechnology | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.01 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | Private - View Profile |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | -0.01 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | Private - View Profile |
|---|
| Merck Serono S.A. | Private - View Profile |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.02 | 85.82B | 31.52 |
|---|
| MedImmune, L.L.C. | Private - View Profile |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.01 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | Private - View Profile |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.02 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private - View Profile |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.02 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | -0.01 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.01 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.01 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | -0.01 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | -0.01 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | -0.01 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | -0.01 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.01 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
- GSK
- 3 Most Important Upcoming FDA Decisions of 2013 at Motley Fool Fri 6:33pm
- OREX
- Orexigen Therapeutics to Present at the UBS Global Healthcare Conference PR Newswire Fri 4:01pm
- GSK
- The Billion Dollar COPD Deal: Who Gains The Most? at Seeking Alpha Fri 11:27am
- RHHBY
- Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy at Seeking Alpha Fri 7:25am
- RHHBY
- Good News for Roche's Tarceva Zacks Thu, May 16
- GSK
- Cheerleaders: Look Beyond Pharma For Jobs YCharts Thu, May 16
- OREX
- Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager Finny Kuruvilla Discusses His Portfolio Construction Strategy with The Wall Street Transcript Wall Street Transcript Thu, May 16
- GSK
- Time To Show Optimism For Stocks at Seeking Alpha Thu, May 16
- RHHBY
- Pipeline Progress at Gilead Zacks Thu, May 16
- GSK
- Prestige Slides On Revenue Miss But Vows More Buys at Investor's Business Daily Thu, May 16
- OREX
- Orexigen Therapeutics' Management Presents at Bank of America Merrill Lynch Health Care Conference - Transcript at Seeking Alpha Wed, May 15
- RHHBY
- Melanoma Treatment Harnesses Immune System to Combat Cancer Cells at New York Times Wed, May 15
- RHHBY
- Cancer Meeting Highlights the Good and Bad of the Immune System at Motley Fool Wed, May 15
- OREX
- Weight Loss Isn't Just for Looking Good Anymore at Motley Fool Wed, May 15
- OREX
- OREXIGEN THERAPEUTICS, INC. Financials EDGAR Online Financials Wed, May 15
All Headlines for these symbols... Currency in USD. | |
|
0.02(0.25%) May 17, 4:00PM EDT|After Hours
:
8.00